Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries.
Saved in:
| Title: | Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries. |
|---|---|
| Authors: | Simmonds NJ; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address: nicholasjames.simmonds@nhs.net., Charman SC; Cystic Fibrosis Trust, London, United Kingdom., Wosniok J; Interdisciplinary Center for Clinical Trials Mainz, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Haugh C; Cystic Fibrosis Trust, London, United Kingdom., Santoro D; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy., Fiorini S; Global Regulatory Affairs and Patient Safety, Chiesi Farmaceutici S.p.A., Parma, Italy., Charretier R; Global Clinical Development, Chiesi SAS, Paris, France., Sanchez C; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy., Procaccianti C; Global Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy., Naehrlich L; Department of Pediatrics, Justus-Liebig- University Giessen, Giessen, Germany. |
| Source: | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2026 Mar 18. Date of Electronic Publication: 2026 Mar 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
